Newell Rubbermaid, Inc. (NWL) Tops Q4 EPS by 2c; Guides FY12 EPS, Revs Growth
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts NWL Hot Sheet
Price: $5.36 -6.46%
Revenue Growth %: +3.3%
Financial Fact:
Dividends per share: 0.19
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Revenue Growth %: +3.3%
Financial Fact:
Dividends per share: 0.19
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Newell Rubbermaid, Inc. (NYSE: NWL) reported Q4 EPS of $0.40, $0.02 better than the analyst estimate of $0.38. Revenue for the quarter came in at $1.5 billion versus the consensus estimate of $1.49 billion.
Newell Rubbermaid, Inc. sees FY2012 EPS of $1.63-$1.69, versus the consensus of $1.68. Sees core sales growth of 2 to 3 percent.
For earnings history and earnings-related data on Newell Rubbermaid, Inc. (NWL) click here.
Newell Rubbermaid, Inc. sees FY2012 EPS of $1.63-$1.69, versus the consensus of $1.68. Sees core sales growth of 2 to 3 percent.
For earnings history and earnings-related data on Newell Rubbermaid, Inc. (NWL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- AMTD Digital reports $1.2B in total assets, $42.4M profit
- Pfizer's 25-valent pneumococcal vaccine shows Phase 2 results
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
